SCHEMBL7947741

SCHEMBL7947741

CCOC(=O)C(N)Cc1ccc2[nH]c(=O)oc2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS1 P29475 1/20 0.47
CREBBP Q92793 1/20 0.46
OPRK1 P41145 1/20 0.44
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
OPRD1 P41143 2/20 0.41
IL4I1 Q96RQ9 1/20 0.40
TSHR P16473 1/20 0.40
KMT2A Q03164 2/20 0.40
PDE10A Q9Y233 1/20 0.40
MEN1 O00255 1/20 0.40
SMYD3 Q9H7B4 1/20 0.39
ENPP2 Q13822 1/20 0.39
ATXN2 Q99700 1/20 0.39
SCN9A Q15858 1/20 0.39
HTR1A P08908 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A3 Q01959 1/20 0.38
POLB P06746 1/20 0.38
TDP1 Q9NUW8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3592672 0.89 CREBBP (0.53) NOS1CREBBPOPRK1KDM4EALDH1A1
SCHEMBL3592677 0.89 CREBBP (0.53) NOS1CREBBPOPRK1KDM4EALDH1A1
SCHEMBL18324458 0.83 SLC7A5 (0.50) NOS1CREBBPOPRK1KDM4EALDH1A1
SCHEMBL11601369 0.79 ALDH1A1 (0.46) NOS1CREBBPOPRK1ALDH1A1TSHR
SCHEMBL22057895 0.78 PDE3B (0.51) NOS1CREBBPKDM4EALDH1A1IL4I1
SCHEMBL4143480 0.76 NOS1 (0.50) NOS1CREBBPOPRK1KDM4EALDH1A1
SCHEMBL4586630 0.76 MEN1 (0.47) OPRK1OPRD1KMT2AMEN1SMYD3
SCHEMBL21163220 0.76 NOS1 (0.56) NOS1CREBBPOPRK1KDM4EALDH1A1
SCHEMBL4593675 0.75 CYP3A4 (0.47) OPRK1KDM4EALDH1A1OPRD1SMYD3
SCHEMBL7960935 0.75 SLC7A5 (0.48) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6268378-B1 TREATING AND PREVENTING OSTEOPOROSIS, AND INHIBITING VASCULAR RESTENOSIS, DIABETIC RETINOPATHY, MACULAR DEGENERATION, ANGIOGENESIS, ATHEROSCLEROSIS, INFLAMMATION, VIRAL DISEASE, AND TUMOR GROWTH. MERCK & CO., INC. 2001-07-31 US disclosed
US-6066648-A USEFUL IN INHIBITING BONE RESORPTION, TREATING AND PREVENTING OSTEOPOROSIS, AND INHIBITING VASCULAR RESTENOSIS, DIABETIC RETINOPATHY, MACULAR DEGENERATION, ANGIOGENESIS, ATHEROSCLEROSIS, INFLAMMATION, VIRAL DISEASE, AND TUMOR GROWTH MERCK & CO., INC. (US) 2000-05-23 US disclosed